Metabolism of endogenous and exogenous estrogens in women.

Autor: Stanczyk FZ; Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. Electronic address: fstanczyk@att.net.
Jazyk: angličtina
Zdroj: The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2024 Sep; Vol. 242, pp. 106539. Date of Electronic Publication: 2024 Apr 29.
DOI: 10.1016/j.jsbmb.2024.106539
Abstrakt: Estrogens regulate important processes in reproductive, skeletal, cardiovascular, and central nervous systems that impact women's overall health. Understanding endogenous and exogenously administered estrogen metabolism is vital to determining therapeutic estrogen levels. The present review provides an overview of estrogen metabolites formed in non-pregnant and pregnant women, and those resulting from exogenous estrogen administration. There are four principal endogenous estrogens: estrone (E 1 ), estradiol (E 2 ), estriol (E 3 ), and estetrol (E 4 ). E 4 , which is produced only in pregnancy, has emerged recently as an estrogen with significant therapeutic potential. E 1 , E 2 , and E 3 undergo extensive metabolism primarily through phase I (hydroxylation, oxidation, reduction) and phase II (primarily conjugation) reactions, whereas E 4 undergoes only phase II reactions. Exogenous estrogens commonly used for menopausal treatment and/or contraception, including micronized E 2 , conjugated equine estrogens, and ethinyl estradiol, also undergo phase I and phase II reactions, but differ widely in the types of metabolites formed. The mechanisms by which estrogen metabolites are formed and their excretion in urine, bile, and feces, are still poorly understood. We highlight areas that require further research to foster a better understanding of how estrogen metabolism impacts dosing of oral estrogens for therapeutic use, as well as the physiological regulation of endogenous estrogens.
Competing Interests: Declaration of Competing Interest FZS has previously received funding from Mithra Pharmaceuticals for manuscript writing.
(Copyright © 2024. Published by Elsevier Ltd.)
Databáze: MEDLINE
Externí odkaz: